| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.23 | 3e-11 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-09 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-09 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-09 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-08 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-07 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-07 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-07 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-07 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-07 |